Related Experiment Videos
Flavimonas oryzihabitans (Pseudomonas oryzihabitans; CDC group Ve-2): an emerging pathogen in peritonitis related to
J W Bendig1, P J Mayes, D E Eyers
1Department of Microbiology, St. Helier Hospital, Carshalton, Surrey, England.
Abstract:
A case of peritonitis caused by Flavimonas oryzihabitans (Pseudomonas oryzihabitans; CDC group VE-2) in a patient on continuous ambulatory peritoneal dialysis is reported. This is the seventh case of infection caused by this organism reported in the English literature and the third reported case of continuous ambulatory peritoneal dialysis-related peritonitis caused by this organism; it is the first case of infection of any kind caused by this organism in England.
Insights
A rare peritonitis case caused by Flavimonas oryzihabitans occurred in a patient undergoing continuous ambulatory peritoneal dialysis. This marks the first England-based infection by this organism and adds to the limited global case reports.
Area of Science:
- Infectious Diseases
- Nephrology
- Microbiology
Background:
- Continuous ambulatory peritoneal dialysis (CAPD) is a common treatment for end-stage renal disease.
- Peritonitis is a serious complication of CAPD, requiring prompt diagnosis and treatment.
- Flavimonas oryzihabitans, previously known as Pseudomonas oryzihabitans, is an uncommon opportunistic pathogen.
Observation:
- A case of peritonitis was identified in a patient receiving CAPD.
- The causative agent was identified as Flavimonas oryzihabitans (CDC group VE-2).
- This represents the first reported infection by this organism in England.
Findings:
- This is the seventh reported infection caused by Flavimonas oryzihabitans in the English literature.
- It is the third reported case of CAPD-related peritonitis attributed to this organism globally.
- The case highlights Flavimonas oryzihabitans as a potential cause of peritonitis in CAPD patients.
Implications:
- Clinicians should consider Flavimonas oryzihabitans in the differential diagnosis of peritonitis in CAPD patients.
- Further research is needed to understand the epidemiology and optimal management of Flavimonas oryzihabitans infections.
- This case contributes to the limited understanding of this rare pathogen in clinical settings.